Read + Share
Amedeo Smart
Independent Medical Education
Milanovic S, Lew R, Xiong K, Casavant E, et al. An open-label study on ulotaront's effects on insulin-glucose regulation in schizophrenia patients with metabolic syndrome and prediabetes: Part I. Diabetes Obes Metab 2026;28:103-111.PMID: 41126393
Email
LinkedIn
Privacy Policy